14-50729605-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_020921.4(NIN):​c.5996G>A​(p.Arg1999His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000979 in 1,613,962 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1999C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00097 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00098 ( 2 hom. )

Consequence

NIN
NM_020921.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 1.43

Publications

7 publications found
Variant links:
Genes affected
NIN (HGNC:14906): (ninein) This gene encodes one of the proteins important for centrosomal function. This protein is important for positioning and anchoring the microtubules minus-ends in epithelial cells. Localization of this protein to the centrosome requires three leucine zippers in the central coiled-coil domain. Multiple alternatively spliced transcript variants that encode different isoforms have been reported. [provided by RefSeq, Jul 2008]
NIN Gene-Disease associations (from GenCC):
  • Seckel syndrome 7
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004661709).
BP6
Variant 14-50729605-C-T is Benign according to our data. Variant chr14-50729605-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 435996.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NINNM_020921.4 linkc.5996G>A p.Arg1999His missense_variant Exon 29 of 31 ENST00000530997.7 NP_065972.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NINENST00000530997.7 linkc.5996G>A p.Arg1999His missense_variant Exon 29 of 31 5 NM_020921.4 ENSP00000436092.2

Frequencies

GnomAD3 genomes
AF:
0.000946
AC:
144
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.0130
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000897
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00134
AC:
336
AN:
250846
AF XY:
0.00137
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000958
Gnomad ASJ exome
AF:
0.0121
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.000277
Gnomad NFE exome
AF:
0.00120
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.000980
AC:
1433
AN:
1461682
Hom.:
2
Cov.:
31
AF XY:
0.000939
AC XY:
683
AN XY:
727130
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33472
American (AMR)
AF:
0.00112
AC:
50
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0129
AC:
336
AN:
26134
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39698
South Asian (SAS)
AF:
0.000220
AC:
19
AN:
86194
European-Finnish (FIN)
AF:
0.000543
AC:
29
AN:
53410
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5746
European-Non Finnish (NFE)
AF:
0.000805
AC:
895
AN:
1111934
Other (OTH)
AF:
0.00151
AC:
91
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
71
143
214
286
357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000965
AC:
147
AN:
152280
Hom.:
0
Cov.:
32
AF XY:
0.000860
AC XY:
64
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000481
AC:
20
AN:
41558
American (AMR)
AF:
0.000654
AC:
10
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
45
AN:
3472
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4820
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000897
AC:
61
AN:
68024
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00126
Hom.:
1
Bravo
AF:
0.000945
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.00125
AC:
152
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000872
EpiControl
AF:
0.00107

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NIN: BP4, BS1, BS2

not specified Uncertain:1
Nov 29, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NIN-related disorder Benign:1
Jun 17, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
18
DANN
Benign
0.65
DEOGEN2
Benign
0.0
.;.;.;.;T;T
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.071
N
LIST_S2
Benign
0.62
T;.;.;T;T;T
M_CAP
Benign
0.0042
T
MetaRNN
Benign
0.0047
T;T;T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.90
N;N;.;.;N;.
PhyloP100
1.4
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.22
N;.;N;.;N;N
REVEL
Benign
0.035
Sift
Benign
0.69
T;.;T;.;T;T
Sift4G
Benign
0.25
T;T;T;T;T;T
Vest4
0.098
ClinPred
0.019
T
GERP RS
2.9
Varity_R
0.019
gMVP
0.048
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141405524; hg19: chr14-51196323; COSMIC: COSV99814957; COSMIC: COSV99814957; API